Promomed made a stock of medicines and pharmaceutical substances for a year

Promomed 15 April 2022

It includes both anti-COVID drugs and antibiotics.


The Russian pharmaceutical company Promomed has created a year’s stock of medicines and substances, we are talking about both drugs for coronavirus and antibiotics. This was announced by the chairman of the Board of Directors of Promomed Group, Petr Bely.

«We have done a lot to help the country get rid of such a scourge as COVID. In particular, we have created a year's stock of medicines and substances against COVID, as well as the main antibiotics. Our country is provided with medicines,» he said, speaking at a visiting meeting of the Council on Intellectual Property under the Chairman of the Federation Council.

Bely stressed that there will be no shortage of medicines in Russia.

Promomed Group is a Russian pharmaceutical company engaged in the development, production and promotion of medicines. Promomed's portfolio includes more than 200 drug products, 80% of which are included in the list of vital and essential drugs. The company is working on the formation of a special anti-COVID portfolio. Now it is represented by such products as Esperavir, Areplivir, Enoparin, Radamin Viro and others.

 

Source: tass.ru